Could a mouth spray kill COVID-19 causing virus?
With no available cure or treatment in place, and a vaccine still far from being available for public use, doctors are experimenting with a lot of different therapies and repurposing some drugs (such as dexamethasone, favipiravir and hydroxychloroquine) to treat COVID+ patients.
In a new study, experts are now researching on the idea whether the novel coronavirus infection could be suspended through primary infection sites, such as the mouth or the nose, by administrating drugs to stop the attack.
Swedish life-sciences firm claims their common-cold fighting spray could work
Making a revolutionary claim, Swedish scientists say that one of their homegrown drugs, used to beat common cold can effectively root out 98.3% of COVID-19 causing viruses.
The announcement was made by a Swedish life sciences firm, Enzymatica, who claimed that a mouth spray manufactured by the company, ColdZyme carries the potential of killing the deadly SARS-COV2 virus by a big percentage. The global infection toll for COVID-19 pandemic stands at 14.8 million, with over 6,00,000 reported fatalities.
The news comes after the pharma company conducted pre-clinical trials of the medicine and found positive results against the disease. Sweden currently has over 78,000 active cases and nearly 5000 people have lost their lives.
In a statement, officials from the company said that the spray was also fast-acting, and hence could effectively root out the deadly virus, probably faster than any test or other form of treatment.
"A virucidal efficacy suspension test was conducted using ColdZyme against SARS-CoV-2. ColdZyme deactivated SARS-CoV-2 by 98.3% (1.76 log10) in 20 minutes"
The company's claim of a mouth injection, experts say, could be helpful in stopping and preventing mild to moderate level COVID-19 infections, considering the fact that SARS-COV-2 can stem off in the mouth and nasal cavities and start replicating in the throat, before attacking other vital organs in the body. The product under testing could work by decreasing the viral load of the active virus, and thereby, stopping any attack.
News source:Times of India
With no available cure or treatment in place, and a vaccine still far from being available for public use, doctors are experimenting with a lot of different therapies and repurposing some drugs (such as dexamethasone, favipiravir and hydroxychloroquine) to treat COVID+ patients.
In a new study, experts are now researching on the idea whether the novel coronavirus infection could be suspended through primary infection sites, such as the mouth or the nose, by administrating drugs to stop the attack.
Swedish life-sciences firm claims their common-cold fighting spray could work
Making a revolutionary claim, Swedish scientists say that one of their homegrown drugs, used to beat common cold can effectively root out 98.3% of COVID-19 causing viruses.
The announcement was made by a Swedish life sciences firm, Enzymatica, who claimed that a mouth spray manufactured by the company, ColdZyme carries the potential of killing the deadly SARS-COV2 virus by a big percentage. The global infection toll for COVID-19 pandemic stands at 14.8 million, with over 6,00,000 reported fatalities.
The news comes after the pharma company conducted pre-clinical trials of the medicine and found positive results against the disease. Sweden currently has over 78,000 active cases and nearly 5000 people have lost their lives.
In a statement, officials from the company said that the spray was also fast-acting, and hence could effectively root out the deadly virus, probably faster than any test or other form of treatment.
"A virucidal efficacy suspension test was conducted using ColdZyme against SARS-CoV-2. ColdZyme deactivated SARS-CoV-2 by 98.3% (1.76 log10) in 20 minutes"
The company's claim of a mouth injection, experts say, could be helpful in stopping and preventing mild to moderate level COVID-19 infections, considering the fact that SARS-COV-2 can stem off in the mouth and nasal cavities and start replicating in the throat, before attacking other vital organs in the body. The product under testing could work by decreasing the viral load of the active virus, and thereby, stopping any attack.
News source:Times of India
